Current Status and Unanswered Questions for Food Allergy Treatments
Tài liệu tham khảo
Gupta, 2011, The prevalence, severity, and distribution of childhood food allergy in the United States, Pediatrics, 128, e9, 10.1542/peds.2011-0204
Branum, 2009, Food allergy among children in the United States, Pediatrics, 124, 1549, 10.1542/peds.2009-1210
Sicherer, 2014, Food allergy: epidemiology, pathogenesis, diagnosis, and treatment, J Allergy Clin Immunol, 133, 291, 10.1016/j.jaci.2013.11.020
Liu, 2010, National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006, J Allergy Clin Immunol, 126, 798, 10.1016/j.jaci.2010.07.026
Rona, 2007, The prevalence of food allergy: a meta-analysis, J Allergy Clin Immunol, 120, 638, 10.1016/j.jaci.2007.05.026
Host, 1998, Clinical course of cow's milk protein allergy and intolerance, Pediatr Allergy Immunol, 9, 48
Host, 2002, Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood, Pediatr Allergy Immunol, 13, 23, 10.1034/j.1399-3038.13.s.15.7.x
Savage, 2007, The natural history of egg allergy, J Allergy Clin Immunol, 120, 1413, 10.1016/j.jaci.2007.09.040
Hourihane, 1998, Resolution of peanut allergy: case-control study, BMJ, 316, 1271, 10.1136/bmj.316.7140.1271
Skolnick, 2001, The natural history of peanut allergy, J Allergy Clin Immunol, 107, 367, 10.1067/mai.2001.112129
Fleischer, 2005, The natural history of tree nut allergy, J Allergy Clin Immunol, 116, 1087, 10.1016/j.jaci.2005.09.002
Muraro, 2014, EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community, Allergy, 69, 1046, 10.1111/all.12441
Sampson, 2014, Food allergy: a practice parameter update–2014, J Allergy Clin Immunol, 134, 1016, 10.1016/j.jaci.2014.05.013
Cummings, 2010, The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review, Allergy, 65, 933, 10.1111/j.1398-9995.2010.02342.x
Lieberman, 2011, Quality of life in food allergy, Curr Opin Allergy Clin Immunol, 11, 236, 10.1097/ACI.0b013e3283464cf0
van der Velde, 2013, Food allergy and quality of life: what have we learned?, Curr Allergy Asthma Rep, 13, 651, 10.1007/s11882-013-0391-7
Umasunthar, 2013, Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis, Clin Exp Allergy, 43, 1333, 10.1111/cea.12211
Robbins, 2014, Growth and nutrition in children with food allergy requiring amino acid-based nutritional formulas, J Allergy Clin Immunol, 134, 1463, 10.1016/j.jaci.2014.08.053
Burks, 2012, Oral immunotherapy for treatment of egg allergy in children, N Engl J Med, 367, 233, 10.1056/NEJMoa1200435
Vickery, 2014, Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy, J Allergy Clin Immunol, 133, 468, 10.1016/j.jaci.2013.11.007
Syed, 2014, Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3), J Allergy Clin Immunol, 133, 500, 10.1016/j.jaci.2013.12.1037
Wood, 2016, A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy, J Allergy Clin Immunol, 137, 1103, 10.1016/j.jaci.2015.10.005
Keet, 2012, The safety and efficacy of sublingual and oral immunotherapy for milk allergy, J Allergy Clin Immunol, 129, 448, 10.1016/j.jaci.2011.10.023
Vickery, 2017, Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective, J Allergy Clin Immunol, 139, 173, 10.1016/j.jaci.2016.05.027
Fleischer, 2013, Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial, J Allergy Clin Immunol, 131, 119, 10.1016/j.jaci.2012.11.011
Narisety, 2015, A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy, J Allergy Clin Immunol, 135, 1275, 10.1016/j.jaci.2014.11.005
Kim, 2011, Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization, J Allergy Clin Immunol, 127, 640, 10.1016/j.jaci.2010.12.1083
Burks, 2015, Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial, J Allergy Clin Immunol, 135, 1240, 10.1016/j.jaci.2014.12.1917
US Food and Drug Administration Center for Biological Evaluation and Research. Meeting of the Allergenic Products Advisory Committee. 2016. Available from: https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/AllergenicProductsAdvisoryCommittee/UCM484938.pdf. Accessed September 1, 2017.
Jones, 2009, Clinical efficacy and immune regulation with peanut oral immunotherapy, J Allergy Clin Immunol, 124, 292, 10.1016/j.jaci.2009.05.022
Anagnostou, 2011, Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome, Clin Exp Allergy, 41, 1273, 10.1111/j.1365-2222.2011.03699.x
Schneider, 2013, A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients, J Allergy Clin Immunol, 132, 1368, 10.1016/j.jaci.2013.09.046
Varshney, 2011, A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response, J Allergy Clin Immunol, 127, 654, 10.1016/j.jaci.2010.12.1111
Jones, 2017, Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults, J Allergy Clin Immunol, 139, 1242, 10.1016/j.jaci.2016.08.017
Skripak, 2008, A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy, J Allergy Clin Immunol, 122, 1154, 10.1016/j.jaci.2008.09.030
Baumert, 2018, Quantitative assessment of the safety benefits associated with increasing clinical peanut thresholds through immunotherapy, J Allergy Clin Immunol Pract, 6, 10.1016/j.jaip.2017.05.006
Bock, 2001, Fatalities due to anaphylactic reactions to foods, J Allergy Clin Immunol, 107, 191, 10.1067/mai.2001.112031
Bock, 2007, Further fatalities caused by anaphylactic reactions to food, 2001-2006, J Allergy Clin Immunol, 119, 1016, 10.1016/j.jaci.2006.12.622
Furlong, 2001, Peanut and tree nut allergic reactions in restaurants and other food establishments, J Allergy Clin Immunol, 108, 867, 10.1067/mai.2001.119157
Neuman-Sunshine, 2012, The natural history of persistent peanut allergy, AnnAllergy Asthma Immunol, 108, 326, 10.1016/j.anai.2011.11.010
Clark, 2008, Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center, JAllergy Clin Immunol, 122, 286, 10.1016/j.jaci.2008.05.015
Fleischer, 2012, Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study, Pediatrics, 130, e25, 10.1542/peds.2011-1762
Virkud, 2017, Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy, J Allergy Clin Immunol, 139, 882, 10.1016/j.jaci.2016.07.030
Yee, 2016, The heterogeneity of oral immunotherapy clinical trials: implications and future directions, Curr Allergy Asthma Rep, 16, 25, 10.1007/s11882-016-0602-0
Rachid R. The safety and tolerability of AR101, an oral immunotherapy (OIT) pharmaceutical formulation for peanut allergy, after more than 1 year of treatment: results from an ongoing phase 2b clinical trial (ARC002), including low-dose (300 mg/day) and high-dose (2000 mg/day) maintenance regimens. Abstract presented at: European Academy of Allergy and Clinical Immunology (EAACI) 2016 Annual Congress; June 11-15, 2016; Vienna, Austria.
Bird, 2016, The efficacy of AR101, a peanut-derived pharmaceutical for oral immunotherapy (OIT), is maintained and tolerability is increased with low-dose maintenance therapy, J Allergy Clin Immunol, 137, AB408, 10.1016/j.jaci.2015.12.1265
Jones, 2016, Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy, J Allergy Clin Immunol, 137, 1117, 10.1016/j.jaci.2015.12.1316
Keet, 2013, Long-term follow-up of oral immunotherapy for cow's milk allergy, J Allergy Clin Immunol, 132, 737, 10.1016/j.jaci.2013.05.006
Paassilta, 2016, Children who were treated with oral immunotherapy for cows' milk allergy showed long-term desensitisation seven years later, Acta Paediatr, 105, 215, 10.1111/apa.13251
Lucendo, 2014, Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis, Ann Allergy Asthma Immunol, 113, 624, 10.1016/j.anai.2014.08.004
Gomez Torrijos, 2017, Frequency and course of eosinophilic esophagitis during oral immunotherapy for cow's milk allergy in a series of 57 children, J Investig Allergol Clin Immunol, 27, 132, 10.18176/jiaci.0130
Mondoulet, 2012, Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice, PLoS One, 7, e31967, 10.1371/journal.pone.0031967
Miehlke, 2013, Induction of eosinophilic esophagitis by sublingual pollen immunotherapy, Case Rep Gastroenterol, 7, 363, 10.1159/000355161
Tang, 2015, Administration of a probiotic with peanut oral immunotherapy: a randomized trial, J Allergy Clin Immunol, 135, 737, 10.1016/j.jaci.2014.11.034
Hsiao, 2017, PPOIT Study Team. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial, Lancet Child Adolesc Health, 1, 97, 10.1016/S2352-4642(17)30041-X
MacGinnitie, 2017, Omalizumab facilitates rapid oral desensitization for peanut allergy, J Allergy Clin Immunol, 139, 873, 10.1016/j.jaci.2016.08.010
Dello Iacono, 2013, Specific oral tolerance induction with raw hen's egg in children with very severe egg allergy: a randomized controlled trial, Pediatr Allergy Immunol, 24, 66, 10.1111/j.1399-3038.2012.01349.x
Blumchen, 2010, Oral peanut immunotherapy in children with peanut anaphylaxis, J Allergy Clin Immunol, 126, 83, 10.1016/j.jaci.2010.04.030
Longo, 2008, Specific oral tolerance induction in children with very severe cow's milk-induced reactions, J Allergy Clin Immunol, 121, 343, 10.1016/j.jaci.2007.10.029